Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermalo is a topical bath emollient developed by Dermal Laboratories, a subsidiary of the Diomed Group, for the management of dry skin conditions such as eczema, dermatitis, and ichthyosis. The formulation is a combination of liquid paraffin, isopropyl myristate, and acetylated lanolin alcohols. It is designed to be added to bath water or applied directly to wet skin, where it forms an occlusive film on the skin surface. This oily layer acts as a physical barrier that prevents the evaporation of water from the stratum corneum, thereby restoring the skin's natural moisture levels, soothing irritation, and improving skin barrier function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermalo.